Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Western Union Co — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.74B), while Western Union Co trades at $6.33 (market cap $1.97B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 29.8× Western Union Co's market cap, and Western Union Co pays the higher dividend (14.85%). Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days and Western Union Co for 95 Days on average.
| TAK | WU | |
|---|---|---|
Market Cap | $58.74B | $1.97B |
Volume | 3,110,994 | 10,235,212 |
Sector | Health | Financials |
52-Week High | $19.05 | $10.28 |
52-Week Low | $13.23 | $5.90 |
Typical Hold Time | 0 Days | 95 Days |
Enterprise Value | $86.65B | $1.88B |
Dividend Yield | 3.33% | 14.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Western Union (WU) trades at $6.11, down 0.49% on the day, with bearish technical signals and mixed earnings performance. The stock shows attractive valuation metrics with a P/E of 4.93 and P/S of 0.48, while maintaining strong profitability with 9.79% net margins. Recent developments include the pending Intermex acquisition and expansion of retail partnerships, though earnings misses in Q1 and Q2 2026 raise execution concerns. Cash flow trends show volatility with a $469M net outflow in 2025.
WU presents a value opportunity with deep valuation discounts but faces execution risks amid digital transformation. The $200M cost-cutting plan and Intermex acquisition offer potential upside if successfully implemented, while competitive pressures and integration challenges pose downside risks. Analyst consensus at $6.86 suggests modest upside from current levels, though the mixed rating distribution reflects uncertainty about the turnaround strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
